Accelerated Unilateral Radiographic Huntingtonian Changes Following Neoadjuvant Chemotherapy for a Nongerminomatous Germ Cell Tumor Leading to Identification of Occult Disease in the Dorsal Striatum
- PMID: 26479984
- PMCID: PMC9272520
- DOI: 10.1097/MPH.0000000000000450
Accelerated Unilateral Radiographic Huntingtonian Changes Following Neoadjuvant Chemotherapy for a Nongerminomatous Germ Cell Tumor Leading to Identification of Occult Disease in the Dorsal Striatum
Abstract
Basal ganglia nongerminomatous germ cell tumors comprise 10% to 15% of germ cell tumor and have substantial morbidity at the time of local failure. In this submitted image we present a case where neoadjuvant chemotherapy unmasked a unilateral caudate head loss consistent with Huntingtonian changes. Careful review of the patient's imaging identified disease within the dorsal striatum that was not previously identified at the time of diagnosis. Review of the diffusion tensor fractional anisotropy imaging identified progressive white matter likely secondary to the occult disease within the dorsal striatum. Although this patient was asymptomatic and had no signs of a movement disorder, similar findings have been noted to be a prelude to such findings several months later. The occult disease was incorporated into the patient's radiotherapy planning target volume as oversight of these changes would have led to a marginal miss and potential early disease relapse.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Clinical and Radiologic Features of Pediatric Basal Ganglia Germ Cell Tumors.World Neurosurg. 2016 Nov;95:516-524.e1. doi: 10.1016/j.wneu.2016.08.072. Epub 2016 Aug 24. World Neurosurg. 2016. PMID: 27567571
-
Noncarboplatin-induced Sensorineural Hearing Loss in a Patient With an Intracranial Nongerminomatous Germ Cell Tumor.J Pediatr Hematol Oncol. 2016 May;38(4):312-6. doi: 10.1097/MPH.0b013e318287310e. J Pediatr Hematol Oncol. 2016. PMID: 23652864
-
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.J Clin Oncol. 2015 Aug 1;33(22):2464-71. doi: 10.1200/JCO.2014.59.5132. Epub 2015 Jun 22. J Clin Oncol. 2015. PMID: 26101244 Free PMC article. Clinical Trial.
-
Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature.World Neurosurg. 2020 Feb;134:e360-e371. doi: 10.1016/j.wneu.2019.10.074. Epub 2019 Nov 18. World Neurosurg. 2020. PMID: 31751614 Review.
-
Central Nervous System Germ Cell Tumors: A Review of the Literature.J Child Neurol. 2018 Aug;33(9):610-620. doi: 10.1177/0883073818772470. Epub 2018 May 30. J Child Neurol. 2018. PMID: 29848146 Review.
References
-
- COG-ACNS1123 chemotherapy followed by radiation therapy in treating younger patients with newly diagnosed localized central nervous system germ cell tumors. Available at: https://clinicaltrials.gov/show/NCT01602666. Accessed May 2015.
-
- Phi JH, Cho BK, Kim SK, et al. Germinomas in the basal ganglia: magnetic resonance imaging classification and the prognosis. J Neurooncol. 2010;99:227–236. - PubMed
-
- Okamoto K, Ito J, Ishikawa K, et al. Atrophy of the basal ganglia as the initial diagnostic sign of germinoma in the basal ganglia. Neuroradiology. 2002;44:389–394. - PubMed
-
- Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–381. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical